Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1624 1671 1687 3796
This examiner grants 30% of resolved cases
Meredith Abbott Vassell is an examiner in Art Unit 1624 within Tech Center 3700. The examiner has a total of 66 resolved cases. The allowance rate for these cases is 30.3%. This 30.3% rate indicates a more rigorous examination environment compared to other examiners. Practitioners should be aware that the 30.3% allowance rate suggests a lower probability of success for applications in this art unit.
The median days to allowance is 1726, which represents a long prosecution timeline for successful applications. This 1726-day period should be communicated to clients to manage expectations regarding pendency. However, the data shows a very high interview lift of 47.0%. This 47.0% lift is a critical finding, as it suggests that interviews are exceptionally effective at improving the chances of allowance despite the low base rate. Practitioners should almost always request an interview, as the 47.0% lift provides a significant opportunity to overcome rejections. The 66 resolved cases and 1726-day median pendency highlight the challenging nature of prosecution with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17652946 | INSPECTION VALUE PREDICTION DEVICE, INSPECTION VALUE PREDICTION SYSTEM, AND INSPECTION VALUE PREDICTION METHOD | Final Rejection | Toshiba Digital Solutions Corporation |
| 18330737 | SYSTEMS AND METHODS FOR IDENTIFYING SEQUENCE VARIATION | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 15734269 | REDUCING INHALATION OF POLLUTANTS WHEN TRAVELLING | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18029612 | BIOLOGICAL PARTICLE SORTING DEVICE, BIOLOGICAL PARTICLE SORTING SYSTEM, AND INFORMATION PROCESSING DEVICE | Non-Final OA | Sony Group Corporation |
| 18330283 | CARDIAC SHUNT DEVICE TO MINIMIZE DISRUPTION AND ENHANCE NATURAL FLOW PATTERNS OF BLOOD THROUGH THE HEART | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18146123 | MACHINE LEARNING SOLUTION TO PREDICT PROTEIN CHARACTERISTICS | Non-Final OA | MICROSOFT TECHNOLOGY LICENSING, LLC |
| 18372896 | SEMI-EMPIRICAL WATER MODEL FOR SIMULATING CHEMICAL REACTIONS IN WATER | Non-Final OA | International Business Machines Corporation |
| 17669258 | METHOD FOR CORRECTING DATA RELATED TO ELECTROPHORESIS, METHOD FOR DETERMINING WHETHER PEAK IS SAMPLE-DERIVED PEAK OR SPIKE, APPARATUS, AND PROGRAM | Non-Final OA | HITACHI, LTD. |
| 17636272 | SINGLE-CELL MODELING OF CLINICAL DATA TO DETERMINE RED BLOOD CELL REGULATION | Final Rejection | The General Hospital Corporation |
| 17889778 | FLUORESCENCE IMAGE ANALYSIS METHOD, FLUORESCENCE IMAGE ANALYZER, FLUORESCENCE IMAGE ANALYSIS PROGRAM | Non-Final OA | SYSMEX CORPORATION |
| 17766008 | PROCESS AND DEVICE FOR DETERMINING A RESPIRATORY AND/OR CARDIOGENIC SIGNAL | Final Rejection | Drägerwerk AG & Co. KGaA |
| 16579805 | MIXTURE MODEL FOR TARGETED SEQUENCING | Final Rejection | Grail, Inc. |
| 18169834 | TUMOR FRACTION ESTIMATION USING METHYLATION VARIANTS | Non-Final OA | Grail, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy